Imad Karam
Internal Medicine · Chesterfield, MONPI 1770193054
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,610 of the $5,520 with a category attached, or 83.5%. It is spread thinly across 31 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $49.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$867
- AstraZeneca$642
- Seagen Inc.$502
- E.r. Squibb & Sons, L.L.C.$373
- Daiichi Sankyo Inc.$331
- Sanofi$291
- plus $3K from 25 others
What the payments were for
- Food & beverage$4,61084%
- Education$91016%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 15 | $867 |
| AstraZeneca(2 entities) | 12 | $642 |
| Seagen Inc. | 4 | $502 |
| E.r. Squibb & Sons, L.L.C. | 6 | $373 |
| Daiichi Sankyo Inc. | 11 | $331 |
| Sanofi | 5 | $291 |
| Regeneron Healthcare Solutions, Inc. | 6 | $285 |
| Pfizer | 7 | $278 |
| Lilly USA, LLC | 4 | $263 |
| Amgen | 2 | $250 |
| Gilead | 4 | $245 |
| AbbVie | 2 | $159 |
| Eisai Inc. | 2 | $150 |
| Exelixis Inc. | 1 | $131 |
| Incyte Corporation | 2 | $126 |
| Taiho Oncology, Inc. | 5 | $104 |
| Bayer | 3 | $76 |
| Puma Biotechnology, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Novartis | 2 | $43 |
| Bristol Myers Squibb | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $36 |
| Karyopharm Therapeutics Inc. | 1 | $34 |
| Genentech USA, Inc. | 2 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $27 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Boehringer Ingelheim | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| GSK | 1 | $17 |
| Array Biopharma Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,520 in reported general payments places this provider in the 90th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Chesterfield
- Daniel MarionChesterfield$15K
- Timothy SmithSaint Peters$428K
- Craig DietzKansas City$226K
- Kevin SuttmoellerKansas City$198K
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Dima DandachiColumbia$157K
- Justin SteinkampSaint Charles$139K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.